Anna Farago is currently the Vice President of Early Development in Oncology at Amgen, a position they began in 2024. They previously held significant roles at Novartis and served as a Senior Clinical Program Leader and Clinical Program Leader. Anna has extensive experience in academia, having been an Assistant Professor of Medicine at Harvard Medical School and a Medical Oncologist at Massachusetts General Hospital. They earned a Doctor of Medicine from Harvard Medical School and a PhD in Biological and Biomedical Sciences from Harvard University, following a Bachelor's degree in Biology from Haverford College. Anna completed a postdoctoral research fellowship at the Massachusetts Institute of Technology and specialized in Hematology/Oncology at Dana-Farber Partners Cancer Care.
This person is not in the org chart
This person is not in any teams
This person is not in any offices